Literature DB >> 29545123

Mucormycosis in Iran: A six-year retrospective experience.

S Dolatabadi1, B Ahmadi2, A Rezaei-Matehkolaei3, H Zarrinfar4, A Skiada5, H Mirhendi6, R Nashibi7, F Niknejad8, M Nazeri9, A Rafiei10, M Gharaghani11, M Erami12, S Taghipour13, F Piri10, K Makimura14.   

Abstract

Mucormycosis is a devastating infection caused by Mucoralean fungi (Mucormycotina, Mucorales). Data concerning the global epidemiology of mucormycosis are scarce and little is known about the characteristics of mucormycosis in Iran. In this study, we aimed to understand the distribution of this infection in Iran retrospectively and to ascertain whether the patterns of infection are associated with specific host factors or not. A total of 208 cases were included in this study occurring during 2008-2014 and were validated according to (EORTC/MSG) criteria. A rising trend as significant increase from 9.7% in 2008 to 23.7% in 2014 was observed. The majority of patients were female (51.4%) with median age of 50 and the infections were seen mostly in autumn season (39.4%). Diabetes mellitus (75.4%) was the most common underlying condition and sinus involvement (86%) was the mostly affected site of infection. Amphotericin B (AmB) was the drug of choice for the majority of cases. Sixty four isolates did not show any growth in the lab and only 21 cases were evaluated by ITS sequencing, among them; Rhizopus arrhizus var. arrhizus was the dominant species. Considering the high mortality rate of mucormycosis, early and accurate diagnosis, with the aid of molecular methods may provide accurate treatments and improve the survival rate. Therefore, increased monitoring and awareness of this life-threatening disease is critical.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Mucormycosis; Rhizopus arrhizus

Mesh:

Substances:

Year:  2018        PMID: 29545123     DOI: 10.1016/j.mycmed.2018.02.014

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  11 in total

1.  Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.

Authors:  Saeed El Zein; Jean El-Cheikh; Aline El Zakhem; Dima Ibrahim; Ali Bazarbachi; Souha S Kanj
Journal:  Infection       Date:  2018-08-18       Impact factor: 3.553

2.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

Review 3.  Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.

Authors:  Mohan Bilikallahalli Sannathimmappa; Vinod Nambiar; Rajeev Aravindakshan
Journal:  Int J Crit Illn Inj Sci       Date:  2022-03-24

4.  Clinical presentations, diagnosis, management, and outcomes of renal mucormycosis: An overview of case reports.

Authors:  Mojtaba Didehdar; Zahra Chegini; Amin Khoshbayan; Alireza Moradabadi; Aref Shariati
Journal:  Front Med (Lausanne)       Date:  2022-08-24

5.  Acute invasive mucormycosis rhinosinusitis causing multigroup cranial nerve injury and meningitis-A case report.

Authors:  Tingting Wang; Duanhua Cao; Jingzhe Han
Journal:  Front Neurol       Date:  2022-10-04       Impact factor: 4.086

6.  Epidemiology, clinical features, therapeutic interventions and outcomes of mucormycosis in Shiraz: an 8-year retrospective case study with comparison between children and adults.

Authors:  Marjan Motamedi; Zahra Golmohammadi; Somayeh Yazdanpanah; S Mojtaba Saneian; Mojtaba Shafiekhani
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

7.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498

Review 8.  Epidemiology and Diagnosis of Mucormycosis: An Update.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  J Fungi (Basel)       Date:  2020-11-02

Review 9.  New insights on mucormycosis and its association with the COVID-19 pandemic.

Authors:  Mona G Alshahawey; Ghadir S El-Housseiny; Noha S Elsayed; Mohammad Y Alshahrani; Lamia Mel Wakeel; Khaled M Aboshanab
Journal:  Future Sci OA       Date:  2021-12-16

10.  Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.

Authors:  Manouchehr Avatef Fazeli; Leila Rezaei; Etrat Javadirad; Khosro Iranfar; Abbas Khosravi; Javad Amini Saman; Pardis Poursabbagh; Mohammad Rasoul Ghadami; Mohammad Mehdi Parandin; Amrollah Dehghani; Touraj Ahmadi Jouybari; Behzad Mahdavian; Nastaran Eivazi; Sohbat Rezaei; Alireza Rezaei; Bashir Emami; Mohadeseh Haqgou; Arezoo Bozorgomid; Babak Sayad
Journal:  Mycoses       Date:  2021-07-31       Impact factor: 4.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.